Article Text

Download PDFPDF

Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets
  1. Huiqin He1,
  2. Benquan Liu1,
  3. Hongyi Luo1,
  4. Tingting Zhang1,
  5. Jingwei Jiang2
  1. 1 Jiangsu Key Lab of Drug Screening, China Pharmaceutical University, Nanjing, China
  2. 2 Institute of Pharmacologic Science, China Pharmaceutical University, Nanjing, China
  1. Correspondence to Dr Jingwei Jiang; jiangjingwei{at}cpu.edu.cn

Abstract

The discovery of targeted drugs heavily relies on three-dimensional (3D) structures of target proteins. When the 3D structure of a protein target is unknown, it is very difficult to design its corresponding targeted drugs. Although the 3D structures of some proteins (the so-called undruggable targets) are known, their targeted drugs are still absent. As increasing crystal/cryogenic electron microscopy structures are deposited in Protein Data Bank, it is much more possible to discover the targeted drugs. Moreover, it is also highly probable to turn previous undruggable targets into druggable ones when we identify their hidden allosteric sites. In this review, we focus on the currently available advanced methods for the discovery of novel compounds targeting proteins without 3D structure and how to turn undruggable targets into druggable ones.

  • big data
  • artificial intelligence
  • novel drugs
  • 3D structure
  • undruggable targets
  • hidden allosteric sites
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors wrote the manuscript. JJ provided guidance and modifications.

  • Funding This work is supported by NSFC (No. 81872892 and No. 2018ZX09735001-004), “Double First-Class” University project (No. CPU2018GY20 and No. CPU2018GY38).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.